T. E. Craven
Longitudinal changes in dietary fat intake and associated changes in cardiovascular risk factors in adults with type 2 diabetes: the ACCORD trial
Diabetes Research and Clinical Practice.
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Lancet (London, England).
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study
BMJ (Clinical research ed.).
Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis
Journal of the American Dietetic Association.
Microvascular effects of intensive blood pressure control and its relation to glycemic control in the ACCORD blood pressure trial
Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]
Reversibility of fenofibrate-induced renal function impairment in ACCORD type 2 diabetic participants [abstract 368-OR]
Map of science